Genes were cluster in a continuous heat map that has been split into three column groups: the end of column group 1 continues at the top of column group 2 and the end of column group 2 continues at the top of column group 3. The columns within column groups represent the six samples: 1 -Type-III tachyzoite, 2 -Type-III Compound 1 48 hrs, 3 -Type-I tachyzoite, 4 -Type-I Compound 1 48 hr, 5 -Type-II tachyzoite, 6 -Type-II Compound 1 48hrs and are colored by the colorbar at far right (yellow-to-red=up-regulated; yellow-to-blue=down-regulated) .
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Behnke et al. Figure S2 . A number of promoters have moderate to high levels of expression in tachyzoites.
Promoter regions (1-1.5 kbp) from various genes were tested for expression in Type III-VEGmsj tachyzoites using the dual luciferase assay. A mixture of 40 µg of the appropriate firefly promoter construct and 20 µg of the control α-tubulin promoter construct was transfected in duplicate and luciferase activity expression measured following 36 h of parasite growth. Light emission values for each promoter tested in the context of driving the firefly luciferase (open bars) and values for the co-transfected control α-tubulin promoter in each experiment (renilla luciferase, solid bars) are plotted on a log scale. Note that while firefly luciferase expression in tachyzoites transfected with the experimental promoters varies over two logs, the expression of the α-tubulinrenilla control construct is reasonably consistent between experiments. Behnke et al. Figure S3 . Mapping of the LHD2, SAG4.2, B-NTPase and Cyst-Wall protein promoters. Transient transfections were performed in duplicate and firefly and renilla luciferase activity was assayed sequentially in each of the samples. Firefly luciferase results were normalized by αtubulin-renilla levels and graphed as the induced level of expression of the indicated full length promoter construct (relative-response-ratio, RRR). For sequential deletion constructs, fold change was also determined with respect to the level of luciferase expression in untreated controls; fold change values and standard deviations in parentheses are included for each sequential deletion construct. Nucleotide positions in these deletion studies are referenced with respect to the start of translation (+1) in each construct. (A). Results of sequential deletion of the LDH2 promoter compared to the full length -1509 bp promoter construct. (B). Results of internal deletion of the LDH2 promoter with respect to the -708 bp promoter (which is fully active and comparable to the -1509 bp construct). Note the region identified by sequential deletion are referenced by arrow in the internal deletion series. Two discrete sequence spans were observed to be required for induction of the LDH2 promoter. (C). Results of sequential deletion of the SAG4.2 promoter (fold change values also included) with respect to the 1,609 bp full length promoter. The loss of promoter activity associated with the sequential deletion between -616-416 caused a loss of relative promoter activity, although the fold change values were less affected. Further internal deletions are necessary to resolve whether this cis-element region is a basal rather than inductive element. (D). Results of sequential deletion of the cyst wall (65 kDa protein) promoter identified a region between -899 and -688 bp as required for bradyzoite induction. Note also that the deletion between -1099 and -899 leads to a substantial increase in luciferase over the -1501 full length promoter control indicating the presence of a possible repressor element. Behnke et al. Table S1 . BAG1, B-NTPase and LDH2 promoter induction in Type I, II and III parasites under two different induction conditions (fold change and standard deviation values).
For each construct, fold change was also determined with respect to the level of luciferase expression in the co-transfected α-tubulin-renilla control. Note, the fold change for all three promoter is significantly lower in the Type-I strain as compared to Type-II and III. 
